Health
UIC conducts three clinical trials to study blood clot prevention in COVID-19 patients – News-Medical.Net
The University of Illinois Chicago will conduct three clinical trials for studying blood clot prevention in patients with COVID-19.
Reviewed by Emily Henderson, B.Sc.Nov 18 2020
The University of Illinois Chicago will conduct three clinical trials for studying blood clot prevention in patients with COVID-19.
Blood clots are one of the leading complications of COVID-19. Patients with COVID-19 often form blood clots throughout their bodies, which, if untreated, can lead to organ damage, including stroke, pulmonary embolism and heart attacks. We need to stop blood clot formation in order to prevent these potentially fatal complications…
-
General10 hours agoFerries and celebrities as pollies dash to win the west
-
Noosa News14 hours agoCSIRO, winemakers pair to breed mildew, climate-resistant grapevines
-
Business15 hours ago3 ASX 200 stocks I’d buy and hold for the next 10 years
-
General15 hours agoAdam Scott misses cut for first time in 16 years as Rory McIlroy roars into Masters contention